Back

Ratio of regurgitant fraction to aortic valve area for risk stratification of patients with mixed aortic valvular disease

1 September 2025 (13:15 - 13:25)
Organised by: Logo
Congress Presentation Part of: Advanced echocardiography for risk stratification in valve disease Valvular Heart Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mrs Pilar Lopez Santi

Leiden University Medical Center, Leiden (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Impact of right ventricle to pulmonary artery coupling on outcomes in patients with primary mitral regurgitation
Doctor N. Elmasry (Leiden, NL)
Abstract Slides
Presentation thumbnail
Determinants and prognostic impact of left ventricular remodeling in patients with Atrial Functional Mitral Regurgitation: a subanalysis from the REVEAL-AFMR
Doctor A. Sakamoto (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Comparison of TEE-Related Silent Gastro-Esophageal (GE) Lesions After Mitral Transcatheter Edge-to-Edge Repair (M-TEER) and Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER)
Mrs V. Arsenova (Cottbus, DE)
Abstract Slides
Presentation thumbnail
Ensuring the path to correct AS diagnosis - is AI an adequate and promising tool?
Doctor R. Botan (Dresden, DE)
Abstract Slides
Presentation thumbnail
Association of right atrioventricular coupling indices and right atrial stiffness index with outcome in secondary tricuspid regurgitation
Mrs A. Clement (Iasi, RO)
Abstract Slides

Access the full session

Session thumbnail
Advanced echocardiography for risk stratification in valve disease
Video

The Event

Event poster

ESC Congress 2025

1 September 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
A new perspective on mixed moderate aortic valve disease
thumbnail
Congress Presentation
Association of transaortic flow rate with outcomes in patients with moderate aortic stenosis
thumbnail
Congress Presentation
Right atrial-to-right ventricular area ratio: prognostic value in patients with secondary tricuspid regurgitation

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources